M. Saddik et R. Lai, CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast, J CLIN PATH, 52(11), 1999, pp. 862-864
Citations number
12
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Background-It has been shown that CD44 variants are differentially expresse
d in normal and neoplastic breast tissues. The diagnostic value of these ma
rkers in distinguishing benign from malignant breast lesions has not been w
ell examined.
Aims-To evaluate the diagnostic value of CD44s in distinguishing between in
traductal papillomas and papillary carcinomas of the breast, which may be d
ifficult morphologically.
Methods-Expression of CD44s detected by immunohistochemistry was studied in
a series of intraductal papillomas (11) and papillary carcinomas (10). The
normal breast tissues surrounding the lesions of these cases served as a c
ontrol. The number of CD44s positive epithelial cells was scored and catego
rised as < 10%, 10-70%, or > 70%.
Results-Normal breast epithelial cells and all intraductal papillomas (11 o
f 11) expressed CD44s in a high proportion of cells (> 70%). In contrast, t
he majority of papillary carcinoma cases (eight of 10) expressed this marke
r in < 10% of the cells. In the remaining two papillary carcinoma cases, po
sitivity was seen in more than 10% but still less than 70% of the cells.
Conclusions-CD44s detection by immunohistochemistry is useful in distinguis
hing intraductal papillomas from papillary carcinomas of the breast.